PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)

Clinical trial NCT05357846 · RECRUITING

Trial details

NCT number: NCT05357846
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Squamous Cell Esophageal Carcinoma Esophageal Cancer Oesophageal Cancer

Start date: 2022-11-01
Primary completion: 2031-01-01
Enrollment: 422

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.